HTRA3 is Reduced in Ovarian Cancers Regardless of Stage
- 25 September 2014
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 32 (9) , 464-469
Abstract
Ovarian cancer is the leading cause of death in gynaecological cancers. The high temperature requirement factor A3 (HtrA3) is involved in the pathogenesis of ovarian cancer. In this study we investigated whetherHtrA3 protein levels were altered in subtypes of ovarian cancer and whether HtrA3 down-regulation was associated with peritoneal metastasis. Ovarian cancer tissues from 89 patients were analyzed by immunohistochemistry. The levels of HtrA3 protein were lower in all subtypes of ovarian cancer and the lowest levels of HtrA3 were in epithelial ovarian cancer. The down-regulation of HtrA3 levels was not correlated with peritoneal metastasis of epithelial ovarian cancer.Keywords
This publication has 25 references indexed in Scilit:
- HTRA proteases: regulated proteolysis in protein quality controlNature Reviews Molecular Cell Biology, 2011
- High-temperature requirement factor A3 (Htra3): A novel serine protease and its potential role in ovarian function and ovarian cancersMolecular and Cellular Endocrinology, 2010
- Influence of ovarian stage on transcript profiles in fathead minnow (Pimephales promelas) ovary tissueAquatic Toxicology, 2010
- HtrA proteins as targets in therapy of cancer and other diseasesExpert Opinion on Therapeutic Targets, 2010
- Evolutionary conservation of mammalian HTRA3 and its developmental regulation in the rat ovaryJournal of Experimental Zoology Part B: Molecular and Developmental Evolution, 2009
- HTRA3 expression in non-pregnant rhesus monkey ovary and endometrium, and at the maternal-fetal interface during early pregnancyReproductive Biology and Endocrinology, 2008
- Serine Peptidase HTRA3 Is Closely Associated with Human Placental Development and Is Elevated in Pregnancy Serum1Biology of Reproduction, 2006
- Annual Report to the Nation on the Status of Cancer, 1975–2002, Featuring Population-Based Trends in Cancer TreatmentJNCI: Journal of the National Cancer Institute, 2005
- The HtrA Family of ProteasesMolecular Cell, 2002
- Molecular Cloning of the CA125 Ovarian Cancer AntigenJournal of Biological Chemistry, 2001